C92.62
Acute myeloid leukemia with 11q23-abnormality in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute myeloid leukemia (AML) with 11q23 abnormality in relapse is a specific subtype of leukemia characterized by the uncontrolled growth of abnormal myeloid cells in the bone marrow and blood. This condition involves a genetic change known as the 11q23 abnormality, often associated with a poorer prognosis. The term 'relapse' indicates that the disease has returned after initial treatment. Understanding this diagnosis can help patients and families better grasp the nature of the disease, its potential progression, and the importance of ongoing medical care.
Causes & Symptoms
Clinical Causes: Genetic mutations involving the 11q23 chromosomal region, often resulting in MLL gene rearrangements Previous exposure to certain chemotherapy agents, which may cause genetic alterations leading to leukemia Environmental factors and exposure to toxic chemicals, though specific causes are not well-established Family history of leukemia or other hematologic malignancies in some cases
Key Symptoms: Fatigue and weakness Unexplained fever or chills Easy bruising or bleeding (such as frequent nosebleeds or bleeding gums) Pale skin due to anemia Frequent infections or persistent infections Bone or joint pain Shortness of breath Swollen lymph nodes or spleen Weight loss and loss of appetite
Diagnostic & Treatment
Diagnosis Path: Diagnosis of AML with 11q23 abnormality involves a combination of tests and procedures:
Treatment Protocols: Treatment strategies for AML with 11q23 abnormality in relapse typically include aggressive and targeted approaches:
Clinical Advice & FAQs
Billing Guidance
Is C92.62 a billable ICD-10 code?
Yes, C92.62 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.62?
Clinical documentation must specify the nature of Acute myeloid leukemia with 11q23-abnormality in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference